Management of RSV infections in adult recipients of hematopoietic stem cell transplantation

Jharna N. Shah, Roy F. Chemaly

Research output: Contribution to journalReview article

145 Scopus citations

Abstract

Respiratory syncytial virus (RSV) is a common cause of seasonal respiratory viral infection in patients who have undergone hematopoieticstemcell transplantation.RSV usually presents as an upper respiratory tract infection in this patient population but may progress rapidly to lower respiratory tract infection. Available therapies that have been used for the treatment of RSV infections are limited to ribavirin, intravenous immunoglobulin, and palivizumab. The use of aerosolized ribavirin, alone or in combination with either palivizumab or intravenous immunoglobulin, remains controversial. In this comprehensive review, we present and discuss the available literature on management of RSV infections in adult hematopoietic stem cell transplantation recipients with a focus on therapeutic modalities and outcomes.

Original languageEnglish (US)
Pages (from-to)2755-2763
Number of pages9
JournalBlood
Volume117
Issue number10
DOIs
StatePublished - Mar 10 2011

ASJC Scopus subject areas

  • Biochemistry
  • Immunology
  • Hematology
  • Cell Biology

Fingerprint Dive into the research topics of 'Management of RSV infections in adult recipients of hematopoietic stem cell transplantation'. Together they form a unique fingerprint.

  • Cite this